Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: dutton: we are raising our price target to $0.90 per share

Dutton is really a waste of time

posted on Dec 11, 2007 05:17PM

1. Who puts a speculative buy on a 75 cent stock woith a 90 cent target price. that's  only a 20% upside.  At a 90 cent target is shold be a hold not a buy.

2. They also don;t do their homework since they expect that the last 4 licenses

revenue will not be disclosed until mid 08.  Actaully PTSC is very

 accommodating and they haev a section ebtitles subsequent events

in teh 10-Q where they have been diclosing license dollars closed after teh end of teh reporting

 period

 It's just pathetic how  useless Dutton is.  I'll take ihub over dutton anyday. 

 

Share
New Message
Please login to post a reply